SLS ▲ +1.4% - SELLAS Life Sciences Group, Inc. $SLS - SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026 04-NOV-2026 09:00 AM ET